Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email
temporary image

Ruibai Luo, Ph.D.

  • Program Director
240-760-7475 |

Dr. Ruibai Luo manages a grant portfolio in post-translational modifications, circadian biology, R03s, R15s, and R50s in cancer cell biology. 

In addition to her DCB responsibilities, she also a member of the Trans-NCI Extramural Awareness Group (TEAG) Forum. 

 

Background

Prior to DCB, Dr. Luo worked as a Staff Scientist in NCI’s Center for Cancer Research (CCR).  

Dr. Luo came to DCB because she wanted to view the science from a broader perspective. She says “being a program director gives me the opportunity to still be involved with the research while also being able to view it from a broader perspective.” 

 

Education

  • Ph.D., Biochemistry and Molecular Biology, City University of New York
  • M.S., Molecular Biology, Wuhan University
  • B.S., Biochemistry, Wuhan University
Email